immunotherapy resistance

Hong Kong, April 6, 2026 Promising Results in Immunotherapy-Resistant NSCLC In a significant advancement for lung cancer immunotherapy, Akeso,...

Lyon, France, January 20, 2026 — MaaT Pharma, a late-stage clinical biotechnology company developing microbiome-driven immunotherapies, announced that the...

TURKU, Finland; LONDON, United Kingdom — December 22, 2025 — Faron Pharmaceuticals Ltd, a clinical-stage biopharmaceutical company, has announced...